175 related articles for article (PubMed ID: 32418314)
1. Clinical Application of Mass Spectrometry-Based Proteomics in Lung Cancer Early Diagnosis.
Gasparri R; Sedda G; Noberini R; Bonaldi T; Spaggiari L
Proteomics Clin Appl; 2020 Sep; 14(5):e1900138. PubMed ID: 32418314
[TBL] [Abstract][Full Text] [Related]
2. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
[TBL] [Abstract][Full Text] [Related]
3. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for the lung cancer diagnosis and their advances in proteomics.
Sung HJ; Cho JY
BMB Rep; 2008 Sep; 41(9):615-25. PubMed ID: 18823584
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
6. Research progress in applying proteomics technology to explore early diagnosis biomarkers of breast cancer, lung cancer and ovarian cancer.
Luo L; Dong LY; Yan QG; Cao SJ; Wen XT; Huang Y; Huang XB; Wu R; Ma XP
Asian Pac J Cancer Prev; 2014; 15(20):8529-38. PubMed ID: 25374164
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
Srivastava A; Creek DJ
Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
[TBL] [Abstract][Full Text] [Related]
8. Application of proteomics in non-small-cell lung cancer.
Cho WC
Expert Rev Proteomics; 2016; 13(1):1-4. PubMed ID: 26577456
[TBL] [Abstract][Full Text] [Related]
9. Proteomic strategies for the characterization and the early detection of lung cancer.
Massion PP; Caprioli RM
J Thorac Oncol; 2006 Nov; 1(9):1027-39. PubMed ID: 17409991
[TBL] [Abstract][Full Text] [Related]
10. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
Corbo C; Cevenini A; Salvatore F
Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
[TBL] [Abstract][Full Text] [Related]
11. Advances in proteomic strategies toward the early detection of lung cancer.
Hassanein M; Rahman JS; Chaurand P; Massion PP
Proc Am Thorac Soc; 2011 May; 8(2):183-8. PubMed ID: 21543799
[TBL] [Abstract][Full Text] [Related]
12. Proteomics for early detection of colorectal cancer: recent updates.
Alnabulsi A; Murray GI
Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727
[TBL] [Abstract][Full Text] [Related]
13. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
[TBL] [Abstract][Full Text] [Related]
15. Proteomic patterns analysis with multivariate calculations as a promising tool for prompt differentiation of early stage lung tissue with cancer and unchanged tissue material.
Waloszczyk P; Janus T; Alchimowicz J; Grodzki T; Borowiak K
Diagn Pathol; 2011 Mar; 6():22. PubMed ID: 21418626
[TBL] [Abstract][Full Text] [Related]
16. Serum proteomics profiling identifies a preliminary signature for the diagnosis of early-stage lung cancer.
Gasparri R; Noberini R; Cuomo A; Yadav A; Tricarico D; Salvetto C; Maisonneuve P; Caminiti V; Sedda G; Sabalic A; Bonaldi T; Spaggiari L
Proteomics Clin Appl; 2023 Mar; 17(2):e2200093. PubMed ID: 36645712
[TBL] [Abstract][Full Text] [Related]
17. [Research Progress of Biomakers Proteomics-based in Lung Cancer].
Xie H; Chen Z; Wang G
Zhongguo Fei Ai Za Zhi; 2015 Jun; 18(6):391-6. PubMed ID: 26104898
[TBL] [Abstract][Full Text] [Related]
18. Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.
Pernikářová V; Bouchal P
Expert Rev Proteomics; 2015; 12(6):651-67. PubMed ID: 26456120
[TBL] [Abstract][Full Text] [Related]
19. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
20. Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer.
Carvalho AS; Cuco CM; Lavareda C; Miguel F; Ventura M; Almeida S; Pinto P; de Abreu TT; Rodrigues LV; Seixas S; Bárbara C; Azkargorta M; Elortza F; Semedo J; Field JK; Mota L; Matthiesen R
Sci Rep; 2017 Feb; 7():42190. PubMed ID: 28169345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
